Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

20. März 2012 07:00 ET | Quelle: Aegerion Pharmaceuticals, Inc.

Aegerion Pharmaceuticals Announces EMA Acceptance for Review of Marketing Authorization Application for Lomitapide

CAMBRIDGE, Mass., March 20, 2012 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), an emerging biopharmaceutical company focused on the development and commercialization of novel...
06. März 2012 07:00 ET | Quelle: Aegerion Pharmaceuticals, Inc.

Aegerion Pharmaceuticals Announces Fourth-Quarter and Full-Year 2011 Financial Results

CAMBRIDGE, Mass., March 6, 2012 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), an emerging biopharmaceutical company focused on the development and commercialization of novel...
05. März 2012 07:00 ET | Quelle: Aegerion Pharmaceuticals, Inc.

Aegerion Pharmaceuticals Submits Marketing Applications for Lomitapide in U.S. and EU

CAMBRIDGE, Mass., March 5, 2012 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), an emerging biopharmaceutical company focused on the development and commercialization of novel...
22. Februar 2012 08:00 ET | Quelle: Aegerion Pharmaceuticals, Inc.

Aegerion Pharmaceuticals to Present at the Citi 2012 Global Healthcare Conference

CAMBRIDGE, Mass., Feb. 22, 2012 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), an emerging biopharmaceutical company focused on the development and commercialization of novel...
09. Februar 2012 08:00 ET | Quelle: Aegerion Pharmaceuticals, Inc.

Aegerion Pharmaceuticals Announces Webcast of Investor Presentations at Upcoming Conferences

CAMBRIDGE, Mass., Feb. 9, 2012 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), an emerging biopharmaceutical company focused on the development and commercialization of novel...
20. Dezember 2011 08:00 ET | Quelle: Aegerion Pharmaceuticals, Inc.

Sandford D. Smith Appointed to Aegerion Pharmaceuticals' Board of Directors

CAMBRIDGE, Mass., Dec. 20, 2011 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), an emerging biopharmaceutical company focused on the development and commercialization of novel...